Filing Details

Accession Number:
0001005201-19-000082
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-06-14 17:20:25
Reporting Period:
2019-06-13
Accepted Time:
2019-06-14 17:20:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1005201 Assertio Therapeutics Inc ASRT Pharmaceutical Preparations (2834) 943229046
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1261506 A Karen Dawes Assertio Therapeutics, Inc.
100 South Saunders Road, Suite 300
Lake Forest IL 60045
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-06-13 12,500 $3.18 100,423 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2019.
  2. The price reported is a weighted average sale price. The shares were sold in multiple same-way transactions on June 13, 2019 at prices ranging from $3.15 to $3.23 per share of common stock. If requested by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares of common stock sold at each separate price.